Step Up for Ovarian Cancer UK

18th of September 2022 – Gynaecological Cancer Awareness Month

This September is Gynaecological Cancer Awareness Month. We’re asking you to Step Up for Ovarian Cancer and join our Kiltwalk team in Edinburgh on the 18th of September, or choose your own event closer to home!

We’ve joined forces with the University of Edinburgh Development Trust to support the leading UK low-grade serous cancer research team at the Edinburgh Cancer Research Centre.

Choose from the Wee Wander (3.5-4.5 miles), Big Stroll (14.6 miles) or the Mighty Stroll (24 miles) in Edinburgh – or create your own adventure closer to home on the day.

The goal is simple. To be active and raise vital funds for research to find better treatments to help women with low grade serous ovarian cancer live longer.

Every donation made through the KiltWalk page will be matched by up to 50% by The Hunter Foundation – so your efforts support research go further!

To Sign Up

  1. Choose your distance
  2. Choose Team: Cure Our Ovarian Cancer
  3. Choose Charity: University of Edinburgh Development Trust
Diane Kilt Walk

Diane’s Story

Diane was diagnosed with low-grade serous carcinoma at 49 years old. In the last six years she has had three surgeries, two courses of chemotherapy and several hormone therapy treatments.

As a palliative care nurse specialist she never expected, at the height of her career, to be on the receiving end of palliative care herself.

She continues to tirelessly raise awareness of this disease and to raise money for vital research to find successful treatments with hopefully a cure.

“As long as I’m alive I will fight as hard as I can for research to save other young women from dying with ovarian cancer. Please Step Up and fundraise for research.”

Supporting the search for better treatments

All funds raised for Low Grade Serous Ovarian Cancer (LGSOC) research in the UK are being directed to the Edinburgh Cancer Research Centre, part of the University of Edinburgh, to support Professor Charlie Gourley and his team’s research to improve the survival of women with low-grade serous ovarian cancer. Their world leading research focusses on understanding the genetic and genomic origins of low-grade serous ovarian cancer, and, how this information can be used to better detect and treat this disease.